Antimicrobial resistance and susceptibility testing: An evergreen topic

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 1, 2002, Pages 1-4

  Varaldo, Pietro E ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG INDUSTRY; DRUG UTILIZATION; ENTEROBACTERIACEAE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENICITY; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TREATMENT FAILURE; TREATMENT OUTCOME; ZOONOSIS; BACTERIAL INFECTION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; QUALITY CONTROL; REVIEW; STANDARD;

BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; QUALITY CONTROL;

EID: 0035996084     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf093     Document Type: Article

References (45)

1. Reviving the antibiotic miracle
2. The microbial wars
3. The origin of plagues: Old and new
4. Resistance to antimicrobial drugs-a worldwide calamity
5. Balancing the drug-resistance equation
6. Antibiotic resistance: The new apocalypse?
7. Vancomycin-resistant Staphylococcus aureus: Apocalypse now?
8. Epidemiology of drug resistance: Implications for a post-antimicrobial era
9. Science, medicine, and the future: The development of new antimicrobial agents
10. Vancomycin-resistant bacteria
11. Counterattack: How drugmakers are fighting back
12. Antibiotic resistance: Counting the cost
13. Reducing antibiotic resistance
14. Virulence of antibiotic-resistant Salmonella typhimurium
15. Evasion of antibiotic action by bacteria
16. Can antibiotic-resistant nosocomial infections be controlled?
17. Human infection caused by glycopeptide-resistant Enterococcus spp.: Are they a zoonosis?
18. Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci
19. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: Influence of macrolide resistance on clinical and microbiological outcomes
20. Smal macrorestriction analysis of Italian isolates of erythromycin-resistant Streptococcus pyogenes and correlations with macrolide-resistance phenotypes
21. Resistance as a cause of treatment failure
22. The subtleties of antibiotic resistance
23. In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance
24. A problem with antimicrobial susceptibility tests
25. Measuring the comparative efficacy of antibacterial agents for acute otitis media: The'Pollyanna phenomenon'
26. The role of macrolides in Streptococcus pyogenes pharyngitis
27. Management of antibiotic-resistant pneumococcal infections
28. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain
29. The in vivo-in vitro paradox in pneumococcal respiratory tract infections
30. Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxicillin for pneumonia among children in Pakistan: Randomised controlled trial
31. Decrease in antibiotic susceptibility or increase in resistance?
32. Should we reevaluate antibiotic breakpoints?
33. Reevaluation of antibiotic breakpoints
34. Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard M2-A
35. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A
36. Performance Standards for Antimicrobial Susceptibility Testing: Sixth Informational Supplement M100-S6
37. Performance Standards for Antimicrobial Susceptibility Testing: Eighth Informational Supplement M100-S8
38. Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement M100-S12